Original Research
Published on 22 Jul 2022
V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques
in Vaccines and Molecular Therapeutics
- 4,363 views
- 8 citations










